Literature DB >> 3764477

Case report 381: Membranous lipodystrophy (MLD).

U E Pazzaglia, F Benazzo, C Castelli, M Boiocchi, G Beluffi.   

Abstract

Entities:  

Mesh:

Year:  1986        PMID: 3764477     DOI: 10.1007/bf00355109

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


× No keyword cloud information.
  5 in total

1.  Membranous lipodystrophy: a clinicopathological study of six cases.

Authors:  M Akai; A Tateishi; C H Cheng; K Morii; M Abe; T Ohno; M Ben
Journal:  J Bone Joint Surg Am       Date:  1977-09       Impact factor: 5.284

2.  Neuropsychiatric and genetic aspects of a new hereditary disease characterized by progressive dementia and lipomembranous polycystic osteodysplasia.

Authors:  H P Hakola
Journal:  Acta Psychiatr Scand Suppl       Date:  1972

3.  A lipid metabolic disease-"membranous lipodystrophy"-an autopsy case demonstrating numerous peculiar membrane-structures composed of compound lipid in bone and bone marrow and various adipose tissues.

Authors:  T Nasu; Y Tsukahara; K Terayama
Journal:  Acta Pathol Jpn       Date:  1973-08

4.  Membranous lipodystrophy of bone.

Authors:  C Wood
Journal:  Arch Pathol Lab Med       Date:  1978-01       Impact factor: 5.534

5.  Lipomembranous osteodysplasia: a case report.

Authors:  P Edvardsen; T B Halvorsen; O Nesse
Journal:  Int Orthop       Date:  1983       Impact factor: 3.075

  5 in total
  2 in total

Review 1.  Nasu-Hakola syndrome: polycystic lipomembranous osteodysplasia with sclerosing leucoencephalopathy and presenile dementia.

Authors:  A Verloes; P Maquet; B Sadzot; M Vivario; A Thiry; G Franck
Journal:  J Med Genet       Date:  1997-09       Impact factor: 6.318

2.  Assignment of the locus for PLO-SL, a frontal-lobe dementia with bone cysts, to 19q13.

Authors:  P Pekkarinen; I Hovatta; P Hakola; O Järvi; M Kestilä; U Lenkkeri; R Adolfsson; G Holmgren; P O Nylander; L Tranebjaerg; J D Terwilliger; J Lönnqvist; L Peltonen
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.